Science Set Journal of Cancer Research

About Journal

The Science Set Journal of Cancer Research (ISSN: 3066-8123) is a peer-reviewed, open-access journal dedicated to publishing original, high-quality studies in the field of oncology and cancer biology. The journal serves as a vital platform for oncologists, cancer researchers, molecular biologists, immunologists, healthcare professionals, and policy experts working to understand, treat, and ultimately prevent cancer in its many forms. With a commitment to scientific integrity, innovation, and clinical relevance, this journal supports the global oncology community by providing access to research that enhances our understanding of cancer mechanisms, therapeutic strategies, diagnostic advancements, and patient-centred care.

Cancer remains one of the leading causes of death worldwide, posing enormous scientific, clinical, and societal challenges. As the field of oncology rapidly evolves with new technologies, personalized treatment approaches, and molecular diagnostics, the need for accessible, evidence-based research has never been more critical. The Science Set Journal of Cancer Research strives to contribute to the acceleration of cancer science by curating manuscripts that are methodologically robust, conceptually sound, and practically applicable in both research and clinical contexts.

Scope of Coverage

This journal welcomes contributions that span the entire spectrum of cancer research and clinical oncology, from bench to bedside. Submissions may include basic research that elucidates the molecular and cellular foundations of cancer, translational studies that bridge laboratory discoveries with therapeutic applications, and clinical investigations that assess the safety, efficacy, and outcomes of cancer treatments in real-world settings.

We encourage studies that focus on:

Cancer Cell Biology and Genetics: Articles exploring oncogenes, tumor suppressor genes, epigenetic modifications, cell cycle dysregulation, apoptosis, and other mechanisms driving cancer development and progression.

Molecular and Targeted Therapies: Research on the discovery, design, and application of targeted therapies, including kinase inhibitors, monoclonal antibodies, and molecular diagnostics that guide treatment selection.

Immuno-oncology and Cancer Vaccines: Studies on the role of the immune system in cancer, immune checkpoint inhibitors, CAR-T cell therapy, and vaccine development for cancer prevention or therapy.

Radiation and Chemotherapy: Clinical trials and research evaluating the outcomes, toxicity, and optimization of traditional cancer treatments, as well as strategies for combination therapies.

Early Detection and Diagnostics: Contributions that discuss advances in imaging technologies, liquid biopsies, biomarkers, genomic profiling, and diagnostic algorithms that aid in early diagnosis or personalized risk assessment.

Epidemiology and Public Health: Research addressing cancer trends, risk factor analysis, population-based interventions, screening programs, and health disparities in cancer care delivery.

Palliative and Supportive Care: Articles focused on symptom management, quality of life, psychological support, and end-of-life care for individuals with advanced or terminal cancer.

Oncology Nursing and Patient Navigation: Studies examining the role of nurses, patient advocates, and multidisciplinary care teams in improving cancer care outcomes and patient experience.

Cancer Prevention and Lifestyle Interventions: Evidence-based approaches to cancer prevention, including dietary strategies, physical activity, tobacco cessation, and public education programs.

Interdisciplinary Collaboration and Global Relevance

Cancer research is inherently multidisciplinary, often involving collaborations across molecular biology, clinical medicine, pharmacology, epidemiology, and even data science. The Science Set Journal of Cancer Research reflects this diversity by encouraging submissions that integrate multiple disciplines, promote innovation, and provide practical insights applicable across different healthcare systems and patient populations.

Authors from all regions are invited to contribute, and we particularly welcome work from both well-established academic centres and emerging institutions. Whether the research originates from a tertiary cancer centre or a regional hospital, we believe that scientifically sound and clinically relevant findings can have a global impact.

Editorial Standards and Peer Review

To uphold the highest standards of scholarly publishing, each manuscript submitted to the journal undergoes a meticulous multi-stage review process. Initially, submissions are screened by the editorial board for clarity, originality, and relevance. Suitable manuscripts are then sent for double-blind peer review, where subject matter experts assess the validity, significance, and scientific rigor of the work. Authors receive constructive feedback to improve their manuscript while maintaining academic integrity.

The journal adheres strictly to ethical research practices and requires full transparency regarding potential conflicts of interest, ethical approval for clinical or animal research, and proper citation of all referenced work.

Open Access for Greater Visibility and Impact

As an open-access publication, the Science Set Journal of Cancer Research ensures that all articles are freely accessible to researchers, clinicians, educators, patients, and the wider public. Removing paywalls significantly increases the dissemination and citation of published work and helps democratize access to critical cancer research. All articles are published under a liberal licensing agreement, allowing readers to share and reuse content while providing appropriate attribution to the authors.

We believe that open access plays a key role in advancing equity in cancer care, especially in low- and middle-income countries where access to subscription-based journals may be limited.

Contribution Types and Submission Invitation

We publish a wide range of article types to support diverse research outputs and knowledge dissemination:

- Original Research Articles

- Systematic and Narrative Reviews

- Clinical Case Studies

- Short Communications

- Technical and Methodological Papers

- Editorials and Commentary

Whether you are presenting the results of a randomized controlled trial, reporting a unique case that offers new clinical insights, or reviewing recent progress in targeted therapy, we invite you to submit your work. Every accepted article will contribute to the growing global dialogue in oncology, with the goal of transforming cancer care for the better.